CDKN1C and colorectal carcinoma: The results of this study suggested that miR-92b-3p regulated drug sensitivity of CRC cells by targeting CDKN1C, whereas knockdown of miR-92b-3p up-regulated CDKN1C expression, significantly reversed drug resistance in vivo and in vitro.